Clinical, Biochemical, and Neuroimaging Findings Predict Long-Term Neurodevelopmental Outcome in Symptomatic Congenital Cytomegalovirus Infection

被引:57
|
作者
Alarcon, Ana [1 ]
Martinez-Biarge, Miriam [2 ]
Cabanas, Fernando [2 ]
Hernanz, Angel [3 ]
Quero, Jose [2 ]
Garcia-Alix, Alfredo [1 ]
机构
[1] St Joan de Deu Univ Hosp, Dept Neonatol, Barcelona, Spain
[2] La Paz Univ Hosp, Dept Neonatol, Madrid, Spain
[3] La Paz Univ Hosp, Dept Biochem, Madrid, Spain
来源
JOURNAL OF PEDIATRICS | 2013年 / 163卷 / 03期
关键词
CEREBROSPINAL-FLUID BETA(2)-MICROGLOBULIN; CENTRAL-NERVOUS-SYSTEM; CRANIAL ULTRASOUND; REFERENCE VALUES; CEREBRAL-PALSY; YOUNG INFANTS; BETA-2-MICROGLOBULIN; CHILDREN; NEWBORNS; BLOOD;
D O I
10.1016/j.jpeds.2013.03.014
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To evaluate clinical, biochemical, and neuroimaging findings as predictors of neurodevelopmental outcome in patients with symptomatic congenital cytomegalovirus (CMV). Study design The study cohort comprised 26 patients with symptomatic congenital CMV born between 1993 and 2009 in a single center. Absolute and weight deficit-adjusted head circumference were considered. Cerebrospinal fluid (CSF) investigations included standard cytochemical analysis, determination of beta(2)-microglobulin (beta(2)-m), neuron-specific enolase, and CMV DNA detection. Neuroimaging was classified according to a validated scoring system comprising calcifications, ventriculomegaly, and atrophy, with findings graded from 0 to 3. Systematic long-term neurodevelopmental assessment included motor function, cognition, behavior, hearing, vision, and epilepsy. Sequelae were graded as mild/absent, moderate, or severe; adverse outcome was defined as death or moderate to severe disability. Results Three children died. The mean age at follow-up of the survivors was 8.7 +/- 5.3 years (range, 19 months to 18.0 years). Neonatal findings showing a significant association with adverse outcome were relative microcephaly, CSF beta(2)-m concentrations, and grade 2-3 neuroimaging abnormalities (P < .05). Receiver operator characteristic curve analysis indicated that the most accurate single factor for predicting unfavorable outcome was CSF beta(2)-m > 7.9 mg/L (area under the curve, 0.84 +/- 0.08; sensitivity, 69%; specificity, 100%). The combination of CSF beta(2)-m > 7.9 mg/L and moderate-severe neuroimaging alterations improved predictive ability (area under the curve, 0.92 +/- 0.06; sensitivity, 87%; specificity, 100%). Conclusion Adjusted head circumference, CSF beta(2)-m level, and neuroimaging studies have prognostic significance for neurodevelopmental outcome in newborns with congenital CMV. A combination of early findings improves the predictive value.
引用
收藏
页码:828 / +
页数:8
相关论文
共 50 条
  • [1] Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection
    Boppana, SB
    Fowler, KB
    Vaid, Y
    Hedlund, G
    Stagno, S
    Britt, WJ
    Pass, RF
    [J]. PEDIATRICS, 1997, 99 (03) : 409 - 414
  • [2] Neuroimaging Profiles and Neurodevelopmental Outcome in Infants With Congenital Cytomegalovirus Infection
    Giannattasio, Antonietta
    Bruzzese, Dario
    Di Costanzo, Pasquale
    Capone, Eleonora
    Romano, Antonia
    D'Amico, Alessandra
    Bravaccio, Carmela
    Grande, Claudia
    Capasso, Letizia
    Raimondi, Francesco
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (10) : 1028 - 1033
  • [3] Neonatal and long-term ophthalmological findings in infants with symptomatic and asymptomatic congenital cytomegalovirus infection
    Capretti, Maria Grazia
    Marsico, Concetta
    Guidi, Simonetta Guidelli
    Ciardella, Antonio
    Simonazzi, Giuliana
    Galletti, Silvia
    Gabrielli, Liliana
    Lazzarotto, Tiziana
    Faldella, Giacomo
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2017, 97 : 59 - 63
  • [4] Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection
    Noyola, DE
    Demmler, GJ
    Nelson, CT
    Griesser, C
    Williamson, WD
    Atkins, JT
    Rozelle, J
    Turcich, M
    Llorente, AM
    Sellers-Vinson, S
    Reynolds, A
    Bale, JF
    Gerson, P
    Yow, MD
    [J]. JOURNAL OF PEDIATRICS, 2001, 138 (03): : 325 - 331
  • [5] Neurodevelopmental outcome in children born with symptomatic congenital cytomegalovirus infection
    Cazacu, AC
    Demmler, GJ
    Sellers-Vinson, S
    Greisser, C
    Williamson, WD
    Lorente, AM
    Rozelle, J
    Turcich, M
    Murphy, M
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 319A - 319A
  • [6] Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection
    Ranjit I. Kylat
    Edmond N. Kelly
    Elizabeth Lee Ford-Jones
    [J]. European Journal of Pediatrics, 2006, 165 : 773 - 778
  • [7] Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection
    Kylat, Ranjit I.
    Kelly, Edmond N.
    Ford-Jones, Elizabeth Lee
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (11) : 773 - 778
  • [8] Long-term linguistic outcome in adults with congenital cytomegalovirus infection
    Schmidt, Karolina Falkenius
    Nystrom, Anastasia
    Karltorp, Eva
    Magnusson, Mans
    Lofkvist, Ulrika
    [J]. INFECTIOUS DISEASES, 2024, 56 (01) : 32 - 41
  • [9] Clinical, Biochemical and Neuroimaging Parameters after Thrombolytic Therapy Predict Long-Term Stroke Outcome
    Brouns, Raf
    Sheorajpanday, Rishi
    Kunnen, Jan
    De Surgeloose, Didier
    De Deyn, Peter Paul
    [J]. EUROPEAN NEUROLOGY, 2009, 62 (01) : 9 - 15
  • [10] OUTCOME OF SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS-INFECTION - RESULTS OF LONG-TERM LONGITUDINAL FOLLOW-UP
    PASS, RF
    STAGNO, S
    MYERS, GJ
    ALFORD, CA
    [J]. PEDIATRICS, 1980, 66 (05) : 758 - 762